<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>During the course of replacement therapy, 22-30% of patients with severe <z:e sem="disease" ids="C0684275,C0019069" disease_type="Disease or Syndrome" abbrv="">hemophilia</z:e> A develop alloantibody to factor VIII </plain></SENT>
<SENT sid="1" pm="."><plain>Autoantibodies to coagulation factors rarely occur in elder individuals with previously <z:mpath ids='MPATH_458'>normal</z:mpath> hemostatic mechanisms or in patients with various underlying disorders </plain></SENT>
<SENT sid="2" pm="."><plain>Although the great majority of the acquired inhibitors are directed to factor VIII, the antibodies may arise to every coagulation factor </plain></SENT>
<SENT sid="3" pm="."><plain>The inhibitor antibodies directly inactivate specific clotting factor, or occasionally, they bind to a nonfunctional site, resulting in increased plasma clearance </plain></SENT>
<SENT sid="4" pm="."><plain>In the last decade, we experienced 12 hemophilia A and 3 hemophilia B patients who developed factor VIII and factor VIII and factor IX inhibitor, respectively, 9 patients with autoantibody to factor VIII (<z:e sem="disease" ids="C1096116" disease_type="Disease or Syndrome" abbrv="">acquired hemophilia</z:e>), and 4 patients with <z:e sem="disease" ids="C0272362" disease_type="Disease or Syndrome" abbrv="">acquired von Willebrand syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Among 12 factor VIII inhibitors, 4 patients were identified to have inversion in the factor VIII gene, 1 with 4 bases deletion, and 1 with missense mutation resulting in G479R </plain></SENT>
<SENT sid="6" pm="."><plain>Four of 9 patients with <z:e sem="disease" ids="C1096116" disease_type="Disease or Syndrome" abbrv="">acquired hemophilia</z:e> had underlying disorders of <z:hpo ids='HP_0001890'>autoimmune hemolytic anemia</z:hpo>, <z:e sem="disease" ids="C0024419" disease_type="Neoplastic Process" abbrv="">macroglobulinemia</z:e>, <z:hpo ids='HP_0001025'>urticaria</z:hpo>, and <z:e sem="disease" ids="C0153405" disease_type="Neoplastic Process" abbrv="">pharyngeal cancer</z:e> at the development of factor VIII inhibitor </plain></SENT>
<SENT sid="7" pm="."><plain>Antibody to <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von willebrand</z:e> factor was detected in 3 of 4 patients with <z:e sem="disease" ids="C0272362" disease_type="Disease or Syndrome" abbrv="">acquired von Willebrand syndrome</z:e> </plain></SENT>
</text></document>